126 related articles for article (PubMed ID: 26935921)
1. Biotransformation of Cobicistat: Metabolic Pathways and Enzymes.
Wang P; Shehu AI; Liu K; Lu J; Ma X
Drug Metab Lett; 2016; 10(2):111-23. PubMed ID: 26935921
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method.
Midde NM; Rahman MA; Rathi C; Li J; Meibohm B; Li W; Kumar S
PLoS One; 2016; 11(2):e0149225. PubMed ID: 26872388
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of the drug-drug interaction potential between cobicistat-boosted antiretroviral regimens and hormonal contraceptives.
Majeed SR; West S; Ling KH; Das M; Kearney BP
Antivir Ther; 2019; 24(8):557-566. PubMed ID: 31933482
[TBL] [Abstract][Full Text] [Related]
4. Rationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDS.
Putcharoen O; Do T; Avihingsanon A; Ruxrungtham K
Drug Des Devel Ther; 2015; 9():5763-9. PubMed ID: 26566368
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome b5 is a major determinant of human cytochrome P450 CYP2D6 and CYP3A4 activity in vivo.
Henderson CJ; McLaughlin LA; Scheer N; Stanley LA; Wolf CR
Mol Pharmacol; 2015 Apr; 87(4):733-9. PubMed ID: 25657337
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
Tang L; Ye L; Lv C; Zheng Z; Gong Y; Liu Z
Toxicol Lett; 2011 Apr; 202(1):47-54. PubMed ID: 21277363
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
Nielsen LM; Holm NB; Leth-Petersen S; Kristensen JL; Olsen L; Linnet K
Drug Test Anal; 2017 May; 9(5):671-679. PubMed ID: 27400739
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial in healthy subjects to assess the bioequivalence of an atazanavir/cobicistat fixed-dose combination tablet versus administration as separate agents.
Sevinsky H; Tao X; Wang R; Ravindran P; Sims K; Xu X; Jariwala N; Bertz R
Antivir Ther; 2015; 20(5):493-500. PubMed ID: 25361436
[TBL] [Abstract][Full Text] [Related]
9. Identification of human cytochrome P450 enzymes involved in the metabolism of IN-1130, a novel activin receptor-like kinase-5 (ALK5) inhibitor.
Kim YW; Kim YK; Kim DK; Sheen YY
Xenobiotica; 2008 May; 38(5):451-64. PubMed ID: 18421620
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat.
Hossain MA; Tran T; Chen T; Mikus G; Greenblatt DJ
J Pharm Pharmacol; 2017 Dec; 69(12):1786-1793. PubMed ID: 28960344
[TBL] [Abstract][Full Text] [Related]
11. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
[TBL] [Abstract][Full Text] [Related]
12. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
Han SY; Zhao HY; Zhou N; Zhou F; Li PP
J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of tauromustine in liver and lung microsomes from various species.
Tuvesson H; Gunnarsson PO; Seidegård J
Xenobiotica; 1999 Aug; 29(8):783-92. PubMed ID: 10553719
[TBL] [Abstract][Full Text] [Related]
14. Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity.
Shen Q; Zuo M; Ma L; Tian Y; Wang L; Jiang H; Zhou Q; Zhou H; Yu L; Zeng S
Chem Biol Interact; 2014 Dec; 224():89-99. PubMed ID: 25451576
[TBL] [Abstract][Full Text] [Related]
15. CYP2D plays a major role in berberine metabolism in liver of mice and humans.
Guo Y; Li F; Ma X; Cheng X; Zhou H; Klaassen CD
Xenobiotica; 2011 Nov; 41(11):996-1005. PubMed ID: 21787170
[TBL] [Abstract][Full Text] [Related]
16. Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
Gallant JE; Koenig E; Andrade-Villanueva J; Chetchotisakd P; DeJesus E; Antunes F; Arastéh K; Moyle G; Rizzardini G; Fehr J; Liu Y; Zhong L; Callebaut C; Szwarcberg J; Rhee MS; Cheng AK
J Infect Dis; 2013 Jul; 208(1):32-9. PubMed ID: 23532097
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D
Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333
[TBL] [Abstract][Full Text] [Related]
18. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
Emoto C; Iwasaki K
Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
[TBL] [Abstract][Full Text] [Related]
20. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]